• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

bluebird bio, Inc. - Common Stock (NQ:BLUE)

4.970 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about bluebird bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026
March 20, 2026
As of March 20, 2026, Vertex Pharmaceuticals (NASDAQ: VRTX) has officially transcended its long-held identity as "the cystic fibrosis (CF) company." For over a decade, the Boston-based biotech giant... 
Via Finterra
Topics Intellectual Property
News headline image
The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
December 24, 2025
On December 23, 2025, the biotechnology landscape shifted for thousands of patients living with chronic anemia. The U.S. Food and Drug Administration (FDA) granted approval to AQVESME (mitapivat),... 
Via PredictStreet
Topics Economy
News headline image
Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results
November 19, 2025
Boston, MA – November 19, 2025 – Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) experienced a dramatic and immediate market backlash, with its stock plummeting over 51.00% following the announcement of... 
Via MarketMinute
News headline image
Motley Fool Co-Founder David Gardner Reviews Stock Picks ↗
July 11, 2025
Via The Motley Fool
News headline image
bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital
June 02, 2025
From bluebird bio
Via Business Wire
News headline image
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
May 30, 2025
From bluebird bio, Inc.
Via Business Wire
News headline image
bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital
May 27, 2025
From bluebird bio, Inc.
Via Business Wire
News headline image
Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions
May 16, 2025
From bluebird bio, Inc.
Via Business Wire
News headline image
Which stocks are moving on Wednesday? ↗
May 14, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
Top movers analysis in the middle of the day on 2025-05-14: top gainers and losers in today's session. ↗
May 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
Bluebird Bio Shareholders Get New All-Cash Offer From Private Equity ↗
May 14, 2025
Bluebird Bio revised its agreement with Carlyle and SK Capital, adding a $5 per share cash option for stockholders ahead of deal completion. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
May 14, 2025
 
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
May 14, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement
May 14, 2025
From bluebird bio, Inc.
Via Business Wire
News headline image
Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital
May 09, 2025
From bluebird bio, Inc.
Via Business Wire
News headline image
Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio
May 05, 2025
From bluebird bio, Inc.
Via Business Wire
News headline image
bluebird bio confirms that Ayrmid, Ltd. has not delivered a binding offer or obtained necessary financing despite extensive engagement
April 16, 2025
From bluebird bio, Inc.
Via Business Wire
News headline image
Top stock movements in today's session. ↗
March 31, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
BlueBird Shares Are Up Today: What's Going On? ↗
March 31, 2025
Bluebird Bio Inc. (NASDAQ: BLUE) shares are trading higher Monday after the company received an unsolicited takeover offer from Ayrmid Ltd. 
Via Benzinga
News headline image
Monday's session: top gainers and losers ↗
March 31, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
March 31, 2025
 
Via Benzinga
News headline image
Gene Therapy-Focused Bluebird Bio Receives Rival Takeover Offer, Stock Jumps ↗
March 31, 2025
Bluebird Bio reviews an unsolicited $4.50 per share bid from Ayrmid after agreeing to a $3.00 per share buyout with Carlyle and SK Capital. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
March 28, 2025
 
Via Benzinga
News headline image
bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid
March 28, 2025
From bluebird bio, Inc.
Via Business Wire
News headline image
BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of bluebird bio, Inc. - BLUE
March 13, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal ↗
March 11, 2025
Bristol Myers Squibb to acquire 2seventy Bio for $5.00 per share in a $286 million all-cash deal, an 88% premium to its last close. Expected to close in Q2 2025. 
Via Benzinga
News headline image
BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of bluebird bio, Inc. - BLUE
February 24, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Top movers analysis one hour before the close of the markets on 2025-02-21: top gainers and losers in today's session. ↗
February 21, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
Dow Tumbles Over 700 Points; US Services PMI Falls In February ↗
February 21, 2025
 
Via Benzinga
Topics Stocks
News headline image
Top movers in Friday's session ↗
February 21, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap